How often should transesophageal echocardiography be performed to surveil a Watchman left atrial appendage closure device?

Watchman Device Echo Surveillance Schedule

Following left atrial appendage closure with a Watchman device, transesophageal echocardiography should be performed at 45 days and at 1 year post-implantation to assess for device-related thrombus and peridevice leak before discontinuing anticoagulation. 1

Standard Surveillance Protocol

The established surveillance schedule includes:

• Within the first month (typically 45 days): TEE to verify device stability, assess for erosion, evaluate for complete occlusion without peridevice leak, and rule out device-related thrombus 1

• At 6 months: Follow-up echocardiography as part of routine surveillance 1

• At 1 year: TEE to reassess for late complications including device-related thrombus and peridevice leak 1, 2

• Annually thereafter: Ongoing surveillance to ensure device stability, absence of leak, and exclude associated complications 1

Clinical Rationale for This Schedule

Early Surveillance (45 Days)

The 45-day TEE is critical because:

• Device-related thrombus occurs in 3.2% of patients at this timepoint 2
• Peridevice leak is detected in 15.0% of patients at 45 days 2
• This imaging determines eligibility for discontinuation of oral anticoagulation 2
• Two-thirds of device-related thrombus cases occur within 90-180 days post-implantation 1, 3

Late Surveillance (1 Year)

The 1-year TEE remains essential because:

• Device-related thrombus incidence actually increases to 5.6% at 1 year 2
• All device-related thrombus detected at 1 year occurred in patients without prior thrombus at 45 days 2
• Peridevice leak persists in 8.9% of patients at 1 year 2
• Up to 20% of device-related thrombus cases occur later than 6-12 months after the procedure 1, 3

Alternative Surveillance Strategy

An alternative approach delays the first imaging to 4 months post-implantation:

• First TEE or cardiac CT at 4 months, then at 1 year 4
• This strategy showed no ischemic strokes between 45 days and 4 months 4
• Device-related thrombus was detected in 2.4% at 4 months and 0.9% at 1 year 4
• This approach may be considered when using a truncated anticoagulation regimen 4

Long-Term Surveillance Beyond 1 Year

Annual surveillance should continue indefinitely because:

• Device-related thrombus was found in 13% of patients at a median of 3.1 years post-implantation (range 1.0-7.5 years) 5
• The number of patients without detectable leak actually increased at long-term follow-up compared to 6-week assessment 5
• Major peridevice leaks (>5 mm) were detected in 3% of patients during long-term surveillance 5
• Late device complications continue to occur and require ongoing monitoring 5

High-Risk Features Requiring More Intensive Surveillance

Patients with the following characteristics warrant closer monitoring:

• History of prior TIA or thromboembolism: Significantly associated with device-related thrombus or peridevice leak at 1 year 2
• Peridevice leak >3 mm at 45 days: Associated with worse clinical outcomes (69% vs 34% primary outcome occurrence) and higher stroke risk regardless of leak size 6
• Deep device implantation (>10 mm from pulmonary vein limbus): Increases device-related thrombus risk (OR 2.41) 1, 3
• Non-paroxysmal atrial fibrillation: Associated with increased device-related thrombus risk (OR 1.90-2.24) 1, 3
• Renal insufficiency: Increases device-related thrombus risk (OR 4.02) 1, 3

Imaging Modality Selection

Transesophageal Echocardiography

• Primary diagnostic modality with sensitivity 93-100% and specificity 99% for detecting device-related thrombus 3, 7
• Required for definitive assessment of peridevice leak and device stability 1

Cardiac CT

• Can identify subtle changes such as hypoattenuated thickening 1
• Distinguishes low-grade (23.8% incidence, low embolic risk) from high-grade hypoattenuated thickening (5.1% incidence, HR 4.6 for stroke) 1
• May be used as alternative to TEE at 4 months in select protocols 4

Common Pitfalls to Avoid

• Do not discontinue surveillance after 1 year: Late device-related thrombus occurs in 13% of patients during long-term follow-up 5
• Do not ignore small peridevice leaks: Any peridevice leak, regardless of size, is associated with increased risk of thromboembolism, major bleeding, and all-cause death 3
• Do not assume peridevice leaks are stable: Leaks ≤3 mm tend to regress over time (2.2 mm to 1.6 mm), while leaks >3 mm show no significant change 6
• Do not rely solely on transthoracic echocardiography: TEE or cardiac CT is required for adequate visualization of the device and detection of complications 1